The Fc-fusion protein product shows superior results with an annualized bleeding rate (ABR) of 1 1.6 bleeding episodes with individualized prophylaxis and 3.6 bleeding episodes
The Fc-fusion protein product shows superior results with an annualized bleeding rate (ABR) of 1 1.6 bleeding episodes with individualized prophylaxis and 3.6 bleeding episodes